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TBC1D1 and TBC1D4 (also known as Akt
Substrate of 160 kDa, AS160) are paralogue
RabGTPase activatingproteins (Rab-GAPs)
that have attracted a great deal of interest
because they are implicated in the regula-
tion of the trafficking of specialized GLUT4
glucose transporter storage vesicles that
are found in adipose and muscle tissue.
TBC1D4 was originally linked to the con-
trol of insulin-stimulated glucose transport
on the basis of experiments using cultured
adipocytes that expressed TBC1D4 with
mutations to prevent phosphorylation on
specific serine and threonine residues (Sano
et al. 2003). These seminal experiments
revealed that the ability to phosphorylate
key Akt-phosphomotifs on TBC1D4 was
important for controlling insulin-regulated
GLUT4 translocation. These observations
were extended by subsequent research that
focused on the phosphorylation of TBC1D4
in culturedmyocytes or rodent skeletalmus-
cle. Expressing TBC1D4 that was mutated
to prevent phosphorylation on specific ser-
ine or threonine residues resulted in atten-
uated insulin-stimulated glucose uptake by
both cultured myocytes and rodent skeletal
muscles.
Both TBC1D1 and TBC1D4 are expressed
in human skeletal muscle, and each of
these Rab-GAPs in human muscle can
become phosphorylated on selected sites
in response to elevated plasma insulin. The
standard approach for assessing insulin’s
regulation of TBC1D1 and TBC1D4 in
human skeletal muscle has been to infuse
insulin into the vasculature (e.g. during
a euglycaemic–hyperinsulinaemic clamp).
Typically, this procedure aims to maintain
a stable and elevated insulin concentration
for up to 2–3 h with muscle biopsies
sampled at various time-points being used
for analysis of signalling proteins. This
approach provides useful information with
a great deal of experimental control, but a
sustained and high level of plasma insulin
does not replicate the ‘real’ conditionduring
which dynamic changes in the rate of insulin
secretion occur after the ingestion of ameal.
In this issue of The Journal of Physiology,
Treebak et al. (2014) aimed to use a more
physiologically relevant approach for in-
creasing plasma insulin by probing the regu-
lation of TBC1D1 and TBC1D4 site-specific
phosphorylation in skeletal muscle (vastus
lateralis) sampled from a group of men on
two occasions: (1) after an overnight fast
(characterized by low plasma insulin), and
(2) after an overnight fast that was followed
by eating a small carbohydrate-rich meal
corresponding to about 5% of their daily
caloric intake (leading to a modest and
brief increase in plasma insulin).
A number of earlier studies demonstrated
that ex vivo contractile activity of rodent
skeletal muscles in the absence of insulin
can lead to greater phosphorylation of
each protein (Cartee & Wojtaszewski, 2007;
Sakamoto & Holman, 2008; Cartee & Fu-
nai, 2009). Genetic and pharmacological
approaches have implicated contraction ef-
fects on TBC1D1 and TBC1D4 as partic-
ipating in the increased glucose transport
in muscle during and shortly after contrac-
tile activity. Electrically stimulated contrac-
tions by isolated muscle preparations can
provide valuable information about the di-
rect effects of contractile activity, but this
model does not perfectly mimic the more
complex condition of ‘real’ in vivo exercise.
Earlier research has also demonstrated that
in vivo exercise can result in greater phos-
phorylation of TBC1D1 andTBC1D4 inhu-
man muscle, but the previous studies were
performed either with basal insulin levels
or using a euglycaemic–hyperinsulinaemic
clamp. Accordingly, Treebak et al. (2014)
also included an in vivo exercise component
to their study to assess the influence of ex-
ercise with and without a meal-induced in-
crease in plasma insulin levels. Participants
performed a one-legged exercise protocol
(with one leg resting while the other leg per-
formed knee extensor exercise) in the fasted
and meal-fed conditions. With this experi-
mental design, the separate and combined
effects of a physiological insulin level and
in vivo exercise on TBC1D1 and TBC1D4
site-specific phosphorylation levels were de-
termined for each participant.
Treebak et al. (2014) also included exper-
iments using mice. Each of TBC1D1’s four
phospho-sites that were studied exhibited
greater phosphorylation after one-legged
exercise in human vastus lateralis muscle.
For mice that performed in vivo exercise
(treadmill running), phosphorylation was
increased for three of the four TBC1D1
phospho-sites in the extensor digitorum
longus (EDL) muscle, but for none of the
four sites in the soleus (phosphorylation de-
creased on two sites). TBC1D4 phosphory-
lation did not increase for either the EDL or
soleusofmicewith treadmill runningonany
of the five phospho-sites tested (phosphory-
lation decreased on several sites), whereas
exercise resulted in greater phosphoryla-
tion on each of these sites in human vas-
tus lateralis. Treebak et al. (2014) concluded
that ‘transferring findings between species
can be difficult’, but they also acknowl-
edge that neither the intensity nor mode
of the exercise was matched for humans
versus mice. Earlier studies using humans
have demonstrated that exercise effects on
TBC1D4 phosphorylation depend on the
intensity and mode of exercise, and the cur-
rent results for mice revealed that effects of
a given exercise protocol on TBC1D1 can
differ between different muscles. What are
the ‘real’ reasons for the distinct effects on
TBC1D1 and TBC1D4 elicited by exercise
in mice versus humans? Based on available
data, it is unclear the extent to which differ-
ences in experimental designs (exercise pro-
tocols, muscles studied, etc.) contributed
to the different results in mice versus hu-
mans. Regardless, Treebak et al. (2014) have
provided a substantial amount of interest-
ing and novel data with relevance to the
regulation of TBC1D1 and TBC1D4 phos-
phorylation, and their study illustrates that
the thoughtful use of multiple approaches
along with careful interpretation of the re-
sults will be required to fully understand the
regulation of these two ‘really’ important
signalling proteins.
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